Clonazepam tablets recalled over ‘life-threatening’ label mistake
A popular anxiety drug is being recalled over a ‘life-threatening’ label mistake. In a recall alert for certain lots of Clonazepam Orally Disintegrating Tablets, the company that produces the tablets has said the medication is mislabeled with the incorrect strength on the carton.
Clonazepam Recall Grows Over Potentially Life-Threatening Label Error
Sixteen lots of clonazepam orally disintegrating tablets have been recalled because of a packaging error that could have life-threatening consequences.
Anxiety drug clonazepam recalled due to potentially 'life-threatening' labeling error
Tablets of the drug clonazepam, the generic name for Klonopin, which is used to treat epilepsy, panic disorder and muscle spasms, have been recalled for incorrect labeling that could inadvertently cause people to take a potentially fatal higher dose.
Popular anxiety drug clonazepam recalled for labeling error
"Children and adults who inadvertently consume a higher dose of clonazepam could be at increased risk for the adverse events of significant sedation, confusion, dizziness, diminis
Anxiety drug recalled nationally due to ‘possibly life-threatening’ label error
The drugmaker said that the medication’s strength is mislabeled on the cartons, which could lead to patients taking incorrect dosages.
Recall expended nationwide for clonazepam due to labeling error
Endo, Inc., has expanded its voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to mislabeled carton strength and NDC numbers caused by a packaging error.
Nationwide Recall of Anxiety Drug Over Life-Threatening Packaging Error
Endo Inc., based in Pennsylvania, has announced a voluntary recall of 16 lots of Clonazepam Orally Disintegrating Tablets after it discovered that a number of cartons may have been printed with the incorrect strength and National Drug Code (NDC) on them.
Manufacturer issues recall of popular anxiety drug
Drug manufacturer Endo announced on Friday that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, a popular anxiety drug,
Clonazepam, popular anxiety-reducing drug, recalled nationwide for ‘possibly life-threatening’ error
The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the FDA said in the recall.
Popular anxiety drug being recalled nationwide for ‘possibly life-threatening’ error
A popular prescription anxiety drug is being recalled nationwide for a “possibly life-threatening” mistake on the carton. The Pennsylvania-based drug maker Endo announced this week that it is expanding its recall of clonazepam tablets because some cartons bear the incorrect drug strength and wrong drug code.
BREAKING: Widely used anxiety drug recalled over 'life-threatening' labeling error
A widely used anxiety medication taken by nearly 2 million Americans is being recalled nationwide due to a 'life-threatening' labeling error. The recall affects 16 lots of clonazepam, an anti-anxiety drug sold under the brand name Par Pharmaceutical.
Some Clonazepam Pills Recalled Over Incorrect Doses on Label, F.D.A. Says
The agency warned that adults and children who inadvertently took a higher dose of clonazepam than prescribed could ...
Green Matters on MSN4h
FDA Expands Voluntary Clonazepam Recall — What You Need to Know
The makers of Clonazepam Orally Disintegrating Tablets have issued a voluntary recall over mislabeled product packaging.
Clonazepam recall expanded after misprinting on packaging
The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.
Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling
Endo, Inc. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its ...